Significant increase in MIC-A and MIC-B and soluble MIC-A and MIC-B in canine lymphomas

• Published in: Veterinary immunology and immunopathology 2023-10, Vol.264, p.110647-110647, Article 110647
• Main Authors: Lopez-Montaño, Maresa, Jimenez-Ortega, Laura, Cruz-Hernandez, Teresa Rocio, Hernandez-Chavez, Victor Gabriel, Montiel-Cervantes, Laura Arcelia, Reyes-Maldonado, Elba, Vela-Ojeda, Jorge
• Format: Article
• Language: English
• Subjects: Canine lymphomas; MIC-A; MIC-B; NK cells; NKG2D; NKp46
• ISSN: 0165-2427; 1873-2534
• DOI: 10.1016/j.vetimm.2023.110647

Non-Hodkin's lymphoma (NHL) is the most frequent hematologic malignancy in humans and dogs. NKG2D is one of the most critical receptors on NK cells, recognizing their natural ligands on malignant cells such as A and B major histocompatibility complex-related proteins (MIC-A and MIC-B). Soluble molecules (sMIC-A and sMIC-B) can interfere with immune synapsis between NK cells and tumor cells, impeding NK cytotoxicity. The main objectives of this study were to analyze, in dogs with diffuse large B cell lymphoma, NK cell lymphoma, and reactive lymphadenopathies, the role of NK cells, their activating receptors NKG2D and NKp46, and their ligands MIC-A and MIC-B, as well as soluble molecules sMIC-A and sMIC-B. Thirty-six dogs with a possible diagnosis of NHL and eight healthy dogs were studied. NHL was diagnosed in 28 (78 %) dogs; in the other 8 (22 %), reactive lymphadenopathies were present. Most of the lymphomas corresponded to B cell NHL (82 %). The most predominant subtype was diffuse large B cell lymphoma (21, 71.5 %), followed by five cases (18 %) that were Non-B Non-T lymphomas (presumably NK cell lymphomas) and other B cell lymphomas (3, 10.5%). There were no cases of T cell NHL. MIC-A was positive in 7 of 27 (26 %) cases of NHL, and MIC-B in 20 of 27 (74 %) NHL. In non-malignant lymphadenopathies, three (37.5 %) dogs were positive for MIC-A, and five (62.5 %) expressed MIC-B. Dogs with lymphoma had higher numbers of NK cells than eight healthy dogs. In 15 dogs (12 cases with NHL and three cases with reactive adenopathies) and eight controls, there were no differences in the number of NK cells expressing NKP46 and NKG2D. NHL dogs had higher values of sMIC-A and sMIC-B. B-cell and NK cell lymphomas correspond to 86 % and 14 % of all canine lymphomas. MIC-A, MIC-B, and sMIC-A and sMIC-B were increased in canine lymphomas. •In dogs suspected of malignant lymphoproliferative disease, only 78 % corresponds to NHL.•The predominant NHL in dogs was B cell NHL (82 %); most of the cases corresponded to diffuse large B cell lymphoma (71.5 %).•Canine NK cell lymphoma frequency was 18 %.•NHL dogs had higher values of soluble molecules MIC-A and MIC-B.•It is possible that these findings, at least in theory, may interfere with the immune surveillance against cancer cells.